IXHL
Incannex Healthcare LimitedNASDAQHealthcare$2.90-2.03%ClosedMarket Cap: $33.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.46
P/S
387.28
EV/EBITDA
0.58
DCF Value
$11.95
FCF Yield
-54.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-41819.6%
Net Margin
-67722.1%
ROE
-199.1%
ROA
-77.6%
ROIC
-48.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $0.00 | NaN% | $-7.0M | $-6.5M | $-0.60 | — |
| Q4 2025 | $66.6K | 100.0% | $-12.5M | $-35.6M | $-0.60 | — |
| FY 2025 | $86.0K | 100.0% | $-23.8M | $-46.9M | $-40.80 | — |
| Q3 2025 | $0.00 | NaN% | $-8.4M | $-6.6M | $-0.60 | — |
| Q2 2025 | $19.4K | 100.0% | $-8.1M | $-9.5M | $-0.99 | — |
| Q1 2025 | $109.0K | 100.0% | $-9.2M | $-8.0M | $-0.87 | — |
| Q4 2024 | $18.0K | 100.0% | $-14.6M | $-9.7M | $-1.14 | — |
| FY 2024 | $18.0K | 100.0% | $-45.0M | $-27.6M | $-3.42 | — |
| Q3 2024 | $0.00 | NaN% | $-11.4M | $-9.3M | $-1.14 | — |
| Q2 2024 | $0.00 | NaN% | $-11.7M | $-7.7M | $-0.99 | — |
| Q1 2024 | $0.00 | NaN% | $-7.6M | $-1.1M | $-0.24 | — |
| Q4 2023 | $0.00 | NaN% | $-6.1M | $47.3M | $-0.81 | — |